Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Andrew

Showing results (731-740 of 866) with videos related to

Pageof 87
Sort By:
Nature Communications|January 31, 2019
Author Correction: Circulating tumor DNA analysis depicts subclonal architecture and genomic evolution of small cell lung cancerJingying Nong, Yuhua Gong, Yanfang Guan, et al.
Cancer Innovation|July 1, 2024
Integrative genomic and transcriptomic profiling of pulmonary sarcomatoid carcinoma identifies molecular subtypes associated with distinct immune features and clinical outcomesSahil Seth, Runzhe Chen, Yang Liu, et al.
Nature Communications|August 8, 2018
Circulating tumor DNA analysis depicts subclonal architecture and genomic evolution of small cell lung cancerJingying Nong, Yuhua Gong, Yanfang Guan, et al.
Oncogene|December 14, 2019
Correction: Distinct co-acquired alterations and genomic evolution during TKI treatment in non-small-cell lung cancer patients with or without acquired T790M mutationYing Jin, Hua Bao, Xiuning Le, et al.
Nature Communications|February 22, 2020
Immuno-genomic landscape of osteosarcomaChia-Chin Wu, Hannah C Beird, J Andrew Livingston, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 9, 2020
Multifactorial Deep Learning Reveals Pan-Cancer Genomic Tumor Clusters with Distinct Immunogenomic Landscape and Response to ImmunotherapyFeng Xie, Jianjun Zhang, Jiayin Wang, et al.
Oncogene|November 23, 2019
Distinct co-acquired alterations and genomic evolution during TKI treatment in non-small-cell lung cancer patients with or without acquired T790M mutationYing Jin, Hua Bao, Xiuning Le, et al.
Lung Cancer (Amsterdam, Netherlands)|August 16, 2022
Immunogenomic profiling of lung adenocarcinoma reveals poorly differentiated tumors are associated with an immunogenic tumor microenvironmentNeal Akhave, Jiexin Zhang, Erin Bayley, et al.
Nature Communications|May 11, 2021
Leukemia stemness and co-occurring mutations drive resistance to IDH inhibitors in acute myeloid leukemiaFeng Wang, Kiyomi Morita, Courtney D DiNardo, et al.
Journal of Translational Medicine|December 17, 2022
Integrated multi-omic analysis of low-grade ovarian serous carcinoma collected from short and long-term survivorsKwong-Kwok Wong, Nicholas W Bateman, Chun Wai Ng, et al.
Pageof 87

Showing results (731-740 of 866) with videos related to

Sort By:
Pageof 87
Nature Communications|January 31, 2019
Author Correction: Circulating tumor DNA analysis depicts subclonal architecture and genomic evolution of small cell lung cancerJingying Nong, Yuhua Gong, Yanfang Guan, et al.
Cancer Innovation|July 1, 2024
Integrative genomic and transcriptomic profiling of pulmonary sarcomatoid carcinoma identifies molecular subtypes associated with distinct immune features and clinical outcomesSahil Seth, Runzhe Chen, Yang Liu, et al.
Nature Communications|August 8, 2018
Circulating tumor DNA analysis depicts subclonal architecture and genomic evolution of small cell lung cancerJingying Nong, Yuhua Gong, Yanfang Guan, et al.
Oncogene|December 14, 2019
Correction: Distinct co-acquired alterations and genomic evolution during TKI treatment in non-small-cell lung cancer patients with or without acquired T790M mutationYing Jin, Hua Bao, Xiuning Le, et al.
Nature Communications|February 22, 2020
Immuno-genomic landscape of osteosarcomaChia-Chin Wu, Hannah C Beird, J Andrew Livingston, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 9, 2020
Multifactorial Deep Learning Reveals Pan-Cancer Genomic Tumor Clusters with Distinct Immunogenomic Landscape and Response to ImmunotherapyFeng Xie, Jianjun Zhang, Jiayin Wang, et al.
Oncogene|November 23, 2019
Distinct co-acquired alterations and genomic evolution during TKI treatment in non-small-cell lung cancer patients with or without acquired T790M mutationYing Jin, Hua Bao, Xiuning Le, et al.
Lung Cancer (Amsterdam, Netherlands)|August 16, 2022
Immunogenomic profiling of lung adenocarcinoma reveals poorly differentiated tumors are associated with an immunogenic tumor microenvironmentNeal Akhave, Jiexin Zhang, Erin Bayley, et al.
Nature Communications|May 11, 2021
Leukemia stemness and co-occurring mutations drive resistance to IDH inhibitors in acute myeloid leukemiaFeng Wang, Kiyomi Morita, Courtney D DiNardo, et al.
Journal of Translational Medicine|December 17, 2022
Integrated multi-omic analysis of low-grade ovarian serous carcinoma collected from short and long-term survivorsKwong-Kwok Wong, Nicholas W Bateman, Chun Wai Ng, et al.
Pageof 87